Antiphospholipid antibodies in patients with eosinophilia myalgia and toxic oil syndrome

Journal of Rheumatology

Volumn 24, Issue 1, 1997, Pages 69-72

  Carreira, Patricia E ^a,b   Montalvo, M Gregoria ^a   Kaufman, Lee D ^c   Silver, Richard M ^d   Izquierdo, Maravillas ^b   Gomez Reino, Juan J ^a  

^a Research Unit   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c STONY BROOK UNIVERSITY   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

anticardiolipind antibodies; antiphospholipid antibodies; eosinophilia myalgia syndrome; toxic oil syndrome

Indexed keywords

CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY;

ARTICLE; CONTROLLED STUDY; EOSINOPHILIA MYALGIA SYNDROME; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TOXIC OIL SYNDROME;

ANTIBODIES, ANTIPHOSPHOLIPID; CHRONIC DISEASE; EOSINOPHILIA-MYALGIA SYNDROME; FOOD POISONING; HUMANS; PLANT OILS; SYNDROME;

EID: 0031029690     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Sammaritano LR, Gharavi AE, Lockshin MD. Antiphospholipid antibody syndrome: Immunologic and clinical aspects. Semin Arthritis Rheum 1990;20:81-96.
2. McNeil HP, Chesterman CN, Krilis SA: Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991;49:193-280.
3. Alarcón-Segovia D, Cabrai AR: Functional and immunochemical heterogeneity of antiphospholipid antibodies: A classification (editorial). J Rheumatol 1992;19:1166-9.
4. Love PE, Santoro SA: Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990;112:682-98.
5. Toxic Epidemic Study Group: Toxic epidemic syndrome, Spain, 1981. Lancet 1982;2:697-702.
6. Silver RM, Heyes MP, Maize JC, Quearry B, Vionnet-Fuasset M, Sternberg EM: Scleroderma, fasciitis and eosinophilia associated with the ingestion of tryptophan. N Engl J Med 1990;322:874-81.
7. Hetzman PA, Blevins WL, Mayer J, Greenfield B, Ting M, Gleich GJ: Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med 1990;322:869-73.
8. Martinez-Tello FJ, Navas-Palacios JJ, Ricoy JR, et al: Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Spain. Virchows Archiv 1982;397A:261-85.
9. Tazelar HD, Myers JL, Drage CW, King TE Jr, Aguayo S, Colby TV: Pulmonary disease associated with L-tryptophan-induced eosinophilic myalgia syndrome. Chest 1990;97:1032-6.
10. Kaufman LD, Izquierdo M, Gomez-Reino JJ: Toxic oil syndrome and eosinophilia myalgia syndrome: Similar, different or the same disorder? J Rheumatol 1994;21:11-2.
11. Mayeno AN, Belongia EA, Lin F, Gleich GJ: 3-(phenylamino)-alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: A link to the toxic oil syndrome? Mayo Clin Proc 1992;67:1134-9.
12. Gomez-Reino JJ: Immune system disorders associated with adulterated cooking oil. In: Berlin A, Dean J, Draper MH, Smith EMB, Spreafico F, eds. Immunotoxicology. Dordrecht: Martinus Nijhoff, 1987:376-8.
13. Kaufman LD, Varga J, Gomez-Reino JJ, Jimenez S, Targoff IN: Autoantibodies in sera from patients with L-tryptophan-associated eosinophilia-myalgia syndrome. Demonstration of unique antigen-antibody specificities. Clin Immunol Immunopathol 1995;76:115-9.
14. Gomez-Reino JJ, Carreira PE, Izquierdo M, Montalvo G: Anticardiolipin antibodies in toxic epidemic syndrome patients. Clin Exp Rheumatol 1987;(suppl 2)5:25.
15. Harris EN: The Second International Anti-cardiolipin Standardization Workshop/The Kingston Anti-phospholipid Antibody Study (KAPS) Group. Am J Clin Pathol 1990;94:476-84.
16. Vaarala O, Palosuo T, Kleemola M, Aho K: Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986;41:8-15.
17. Facer CA, Agiostratidou G: High levels of antiphospholipid antibodies in uncomplicated and severe Plasmodium falciparum and in P. vivax malaria. Clin Exp Immunol 1994;95:304-9.
18. Canoso RT, Sise HS: Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: Absence of thrombosis. Am J Haematol 1988;27:272-5.
19. Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC: The prevalence and biological significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989;161:369-73.
20. Harris EN, Spinnato JA: Should anticardiolipin tests be performed in otherwise healthy pregnant women? Am J Obstet Gynecol 1991;165:1272-7.
21. Fields RA, Toubbeh H, Searles RP, Bankhurst AD: The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol 1989;16:623-5.
22. Gharavi AE, Harris EN, Asherson RA, Hughes GRV: Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann Rheum Dis 1987;46:1-6.
23. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci (USA) 1990;87:4120-A
24. Galli M, Comfurius P, Maassen C, et al: Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-7.
25. Ternynck T, Avrameas S: Murine natural autoantibodies: A study of their polyspecificities and their affinities. Immunol Rev 1986;94:99-112.
26. Sutiita M, Hohmann A, Comacchio R, Bradley J: Polyspecific human and murine antibodies to diphtheria and tetanus toxoid and phospholipids. Clin Exp Immunol 1988;73:191-7.